These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 33283625)
1. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma. Zhang L; Song M; Zhang F; Yuan H; Chang W; Yu G; Niu Y J Histochem Cytochem; 2021 Mar; 69(3):165-176. PubMed ID: 33283625 [TBL] [Abstract][Full Text] [Related]
2. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer. Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785 [TBL] [Abstract][Full Text] [Related]
3. Gastric Cancer With the Increased Nicotinamide N-methyltransferase-positive Stromal Cells Includes Unfavorable Prognosis-related Cancer-associated Fibroblasts. Numakura S; Uozaki H Anticancer Res; 2024 Apr; 44(4):1653-1660. PubMed ID: 38537979 [TBL] [Abstract][Full Text] [Related]
4. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer. Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726 [TBL] [Abstract][Full Text] [Related]
5. Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma. Win KT; Lee SW; Huang HY; Lin LC; Lin CY; Hsing CH; Chen LT; Li CF Tumour Biol; 2013 Dec; 34(6):3923-31. PubMed ID: 23838801 [TBL] [Abstract][Full Text] [Related]
6. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer. Li J; Yue H; Yu H; Lu X; Xue X BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144 [TBL] [Abstract][Full Text] [Related]
7. Expression profile and prognostic value of NNMT in patients with pancreatic cancer. Xu Y; Liu P; Zheng DH; Wu N; Zhu L; Xing C; Zhu J Oncotarget; 2016 Apr; 7(15):19975-81. PubMed ID: 26942567 [TBL] [Abstract][Full Text] [Related]
8. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts. Eckert MA; Coscia F; Chryplewicz A; Chang JW; Hernandez KM; Pan S; Tienda SM; Nahotko DA; Li G; Blaženović I; Lastra RR; Curtis M; Yamada SD; Perets R; McGregor SM; Andrade J; Fiehn O; Moellering RE; Mann M; Lengyel E Nature; 2019 May; 569(7758):723-728. PubMed ID: 31043742 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide N-methyltransferase protein expression in renal cell cancer. Zhang J; Xie XY; Yang SW; Wang J; He C J Zhejiang Univ Sci B; 2010 Feb; 11(2):136-43. PubMed ID: 20104648 [TBL] [Abstract][Full Text] [Related]
10. NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer. Liu W; Zhu M; Li X; Er L; Li S Dis Markers; 2023; 2023():9226712. PubMed ID: 36817086 [TBL] [Abstract][Full Text] [Related]
11. [Expression of nicotinamide-N-methyltransferase in gastric cancer and its biological and clinicopathological significance]. Wen Z; Liang W; Zhong Y; Sun F; Zhang Q Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jun; 41(6):828-838. PubMed ID: 34238734 [TBL] [Abstract][Full Text] [Related]
12. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803 [TBL] [Abstract][Full Text] [Related]
13. Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer. Zhu AK; Shan YQ; Zhang J; Liu XC; Ying RC; Kong WC Kaohsiung J Med Sci; 2021 Apr; 37(4):305-313. PubMed ID: 33508890 [TBL] [Abstract][Full Text] [Related]
14. Nicotinamide N-Methyltransferase (NNMT) is Involved in Gastric Adenocarcinoma Immune Infiltration by Driving Amino Acid Metabolism. Lu J; Gui W; Tang S; Shi Q; Wang X; Huang L; Shen Y; Yang S; Xiang J; Yuan J; Mo J; Kong X; Huang M; Li X; Lu C Nutr Cancer; 2024; 76(8):745-759. PubMed ID: 38855943 [No Abstract] [Full Text] [Related]
15. Nicotinamide N-methyltransferase expression in squamous cell carcinoma of the vulva. Çelik ZE; Akar S; Fındık S; Aytekin E; Çelik Ç J Obstet Gynaecol; 2022 Aug; 42(6):2325-2330. PubMed ID: 35499473 [TBL] [Abstract][Full Text] [Related]
16. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119 [TBL] [Abstract][Full Text] [Related]
17. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update. Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880 [TBL] [Abstract][Full Text] [Related]
18. NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma. Türkmen O; Müftüoğlu KH; Dinçer N; Çelik ZE; Akar Inan S Turk J Med Sci; 2024; 54(4):804-810. PubMed ID: 39295619 [TBL] [Abstract][Full Text] [Related]